Whalegun
Home

Andrew Hollman Meyer, Chief Business Officer: Janux Therapeutics JANX Sell · Filed 25/03/05

Trade details

Type
Insider sale
Amount
$77,564.04
Shares · price
2,433 sh · $31.88 a share
Held after
83,040 sh
Stock
Janux Therapeutics JANX
Person
Andrew Hollman MeyerChief Business Officer
Trade date
25/03/03
Filed
25/03/05
Days to filing
2 days

Sold 2.8% of holdings

Share of holding sold
2.8%

Janux Therapeutics trades, last 26 weeks

What else happened in Janux Therapeutics around then

Filed or reported within 30 days of the trade day · 25/02/01~25/04/02

Andrew Hollman Meyer's recent trades

  • Andrew Hollman Meyer

    Planned saleJanux Therapeutics

    $28.2K

    Filed 04/13

  • Andrew Hollman Meyer

    Planned saleJanux Therapeutics

    $2.6M

    Filed 01/26

  • Andrew Hollman Meyer

    Planned saleJanux Therapeutics

    $1.7M

    Filed 01/23

  • Andrew Hollman Meyer

    SellJanux Therapeutics

    $25.8K

    Filed 01/02

  • Andrew Hollman Meyer

    Sell10b5-1 planJanux Therapeutics

    $88.7K

    Filed 25/12/03

Andrew Hollman Meyer, Chief Officer — sold $77.6K of Janux Therapeutics JANX · 2.8% of holdings · 10b5-1 plan | Whalegun